Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	20120229 / 20120230 Placebo	384
Overall Study	STARTED	20120229 / 20120230 Etelcalcetide	384
Overall Study	STARTED	20120359 Etelcalcetide	123
Overall Study	Received Etelcalcetide	20120229 / 20120230 Placebo	383
Overall Study	Received Etelcalcetide	20120229 / 20120230 Etelcalcetide	384
Overall Study	Received Etelcalcetide	20120359 Etelcalcetide	123
Overall Study	COMPLETED	20120229 / 20120230 Placebo	90
Overall Study	COMPLETED	20120229 / 20120230 Etelcalcetide	95
Overall Study	COMPLETED	20120359 Etelcalcetide	16
Overall Study	NOT COMPLETED	20120229 / 20120230 Placebo	294
Overall Study	NOT COMPLETED	20120229 / 20120230 Etelcalcetide	289
Overall Study	NOT COMPLETED	20120359 Etelcalcetide	107

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01785875/flow